DOCSLIB.ORG

Alloiococcus Otitis Gen

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Alloiococcus Otitis Gen INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Jan. 1992, p. 79-83 Vol. 42, No, 1 0020-7713/92/010079-05$02.OO/O Copyright 0 1992, International Union of Microbiological Societies Phylogenetic Analysis of Alloiococcus otitis gen. nov. sp. nov. an Organism from Human Middle Ear Fluid M. AGUIRRE AND M. D. COLLINS* Department of Microbiology, AFRC Institute of Food Research, Reading Laboratory, Shinjield, Reading RG2 9AT, United Kingdom The partial 16s rRNA sequence of an unknown bacterium that was originally isolated from middle ear fluids of children with persistent otitis media was determined by reverse transcription. A comparison of this sequence with sequences from other gram-positive species having low guanine-plus-cytosine contents revealed that this bacterium represents a new line of descent, for which the name Alloiococcus otitis gen. nov., sp. nov,, is proposed. The type strain is strain NCFB 2890. Faden and Dryja (7) recently reported the isolation of an MATERIALS AND METHODS unknown organism from typanocentesis fluid collected from middle ears of young children who were suffering from Cultures and biochemical tests. Strains 3621, 4491, 7213, chronic otitis media. The cells of this bacterium were large and 7760T (T = type strain) were received from D. H. Batts gram-positive cocci (often present as diplococci or tetrads) and R. R. Hinshaw, Upjohn Laboratories, Kalamazoo, which phenotypically most closely resembled aerococci and Mich. Cultures were grown on blood agar plates and Todd- streptococci (7). However, the organism differed from aero- Hewitt broth (Oxoid Ltd., Basingstoke, United Kingdom) cocci and streptococci in being catalase positive. Despite supplemented with 5% horse serum at 37°C. Biochemical possessing catalase, the bacterium could not be identified by tests were performed by using the API 20 STREP system using the Staph-Ident system (Analytab Products), and its (API-Biomerieux, Basingstoke, United Kingdom) according taxonomic position remained unresolved (7). to the instructions of the manufacturer. Test preparations 16s rRNA sequence analysis has assumed a central role in were incubated at 37"C, and tests were read after 4 and 24 h ascertaining the phylogenetic relationships of bacteria (17). and 7 days. GAGUUUGAUCCUGGCUCAGGACGAACGCUGGCGGCAUGCCUAAUA~UGCAAGUCGAACGCCAAAUCWCCUGCWG~GGAAGAGGCGGAGUGGCGMC GGGUGAGUAACACGUGAGGAACWGCCCAUAAGAGGGGGAUAACACCCGGAAACGGGUGCUAAUACCGCAUAAG~CCCAGUG~UG~G~~UA AAAGGUGGCUC~ACCGCWAUGGAU~UCGCGGCGCA~AGCUAGWGGUAGGGU~AGGCCUAC~GGC~UGAUG~GUAGCCGACWGAGAGGG UGAUCGGCCACACUGGAACUGAGACACGGUCCAGACUCCUCCUACGGGAGGCAG~GUAGGG~UCWCCA~UGGGUGCAAGC~GAUGGAGC~UGCCGC GUGAGUGAAGAAGGACWCGGWCGUAAAGCUCUGWGWGGGGAAG~CAC~AUAGGAGUCACUGCCUAUCCCWGACGGUACCC~CCAGAAAGUCA CGGCUAACUACGUGCCAGCAGCCGCGGUAAUACGUAGGUGACAAGC~WGUCCGGA~AWGGGCGUAAAGCGAGCGCAGGCGGUCCGGUAAGUCUGAU GUGAAAGCCCACGGCUCAACCGUGGAACGGCAW~~CUGGCGGAC~G~UGUAGCAGAGGAAAGUGGAAWCCAUGUGUAGCGGUGG~U~CGUAG AUAUAUGGAGGAACACCAGUGGCGAAAGCGACUUUCUGGGGCUAUGA~GACGCUGAGGCUCG~GCGUGG~AGCGAAC~~A~AGAUACCCUG~UAG UCCACGCCGUAAACGAUGAGUGCUAAGUGWGGAGGG~CCGCCCW~~UGCUGGAG~~CGCAW~GCACUCCGCCUGGGGA~ACGACCG~G GWGAAACUCAAAAGAAWGACGGGGGACCGCACCGCA~GCGGUGGAGCAUGUGG~AAWCGAAGCAACGCGAAG~C~ACCAGC~GACAUCWCU GCUAGCUUCAGAGAUGAAGCGUUCCCCWCGGGGACAGAAUGACAGGUGGUGCAUGGWGUCGUCAGCUCGUGUCGUGAGAUGWG~W~GUCCCGU~ CGAGCGCAACCCWAUUGWAG~GCCAGCAWGAGWGGGCACUCUAGCAAGACUGCCGGUGAUAAACCGGAGGAA~CG~AUGACGU~U~UC AUGCCCCWAUGAGCUGGGCUACA~CGUGCUA~UGGAUGGUACAACGAGUGGCGAGACCGCGAGG~AGCUMUCUCC~GC~WCU~GWC GGAUUGCAGGCUGCAACUCGCCUGCAUGAAGUCGGAAUCGCUAGUAAUCGCGGAUCAGAAUGCCGCGGUG~WCGWCCCG~UCWGUACA~CCGCC CGUCACACCACGAGAGUCUGAAACACCCCGAAGCCGGCCGGGCAACCA~GGAGCCAGCCGUCGAA FIG. 1. Primary structure of 16s rRNA from Alloiococcus otitis. The first nucleotide and the last nucleotide in the sequence correspond to positions 9 and 1469, respectively, of the E. coli numbering system (2). In recent years this molecule has done much to clarify the DNA base composition. DNA was prepared as described inter- and intrageneric relationships of low-guanine-plus- by Garvie (9). DNA base composition was determined by cytosine (G +C)-content gram-positive cocci (viz., the gen- subjecting the preparations to thermal denaturation in stan- era Aerococcus, Enterococcus, Lactococcus, Leuconostoc, dard saline citrate as described by Garvie (9), using DNA Pediococcus, and Streptococcus) (1, 3-5, 10, 12-16). Be- from Escherichia coli NCDO 1984 as the standard. cause of the possible role of the unknown coccus of Faden Analysis of 16s rRNA. Cells were mechanically broken by and Dryja in middle ear infections (7), we determined the using a Braun homogenizer, and rRNA was purified by using partial 16s rRNA sequence of this organism in order to the procedure of Embley et al. (6). Nucleotide sequences ascertain its precise phylogenetic position. were determined by the Sanger dideoxynucleotide chain termination method directly from rRNA by using avian myeloblastosis virus reverse transcriptase (6). The se- quences generated were aligned, and homology values were determined by using the Beckman Microgenie program (11). Nucleotide substitution rates (K,,, values) were calculated, and an unrooted phylogenetic tree was produced by using * Corresponding author. the algorithm of Fitch and Margoliash (8). 79 80 AGUIRRE AND COLLINS INT. J. SYST.BACTERIOL. TABLE 1. Homology values for a 1,340-nucleotide region of 16s rRNAs of Alloiococcus otitis and other taxa % Homology with rRNA from: Aerococcus viridans 88.7 NCDO 1225T Bacillus subtilis rrNB 87.8 87.6 Brochothrix 85.7 89.0 89.4 thermosphacta NCDO 1676T Camobacterium 89.9 92.5 90.1 90.2 divergens NCDO 2763T Camobacterium 89.5 91.9 90.5 90.7 97.5 piscicola NCDO 2762T Enterococcus cecomm 89.9 92.3 90.6 91.3 94.6 94.1 NCDO 2674T Enterococcus hira e 89.1 91.6 90.3 91.7 94.8 94.6 97.0 NCDO 1258T Lactobacillus 87.2 86.6 88.3 86.2 87.8 87.9 89.3 89.1 acidophilus NCDQ 174gT Lactobacillus brevk 89.0 90.7 88.8 88.1 91.7 92.9 91.6 92.9 89.8 NCDO 1749T Lactobacillus casei 88.9 90.0 88.5 88.5 91.9 92.0 90.7 91.1 89.7 93.5 NCDO 161T Lactobacillus delbmeckii 86.5 87.7 87.2 85.7 87.2 87.2 88.9 89.3 94.3 90.0 89.7 NCDO 213T Lactobacillus plantmum 87.5 90.1 89.1 87.3 91.1 92.1 90.8 91.6 88.9 95.4 93.5 89.0 NCDO 1752T Lactobacillus reuterii 88.6 89.9 87.7 87.3 90.5 90.4 90.6 91.0 91.5 93.1 93.6 91.2 NCDO 2589T Lactococcus gawieae 85.0 88.4 86.1 86.7 87.7 88.1 90.6 89.4 85.1 88.1 87.3 87.1 NCDO 21ST Lactococcus lactis 86.5 88.7 86.9 87.6 88.7 88.8 90.4 90.3 87.1 89.4 88.5 87.9 NCDO 21HT Leuconostoc 85.4 87.5 85.3 85.2 86.6 85.7 87.8 87.2 88.1 87.0 86.9 87.2 mesenteroides NCDO 523T Leuconostoc paranzesen- 85.9 89.3 86.8 87.9 90.1 89.9 90.7 90.7 87.8 90.4 90.4 87.5 teroides NCDO 803T Listeria innocua NCTC 87.8 90.2 91.8 93.1 92.0 91.9 92.2 92.0 87.0 88.3 88.4 86.9 1128gT Pediococcus acidihactici 89.9 89.4 88.7 88.8 92.1 92.0 92.1 92.4 89.5 94.6 93.8 86.9 NCFB 2767T Pediococcus damnosus 89.0 89.9 89.6 88.1 91.8 92.0 91.3 91.6 89.9 94.6 94.9 89.5 NCDO 1832T Staphylococcus xylosus 86.7 90.6 91.6 89.8 89.8 89.6 90.2 90.5 85.8 87.2 87.5 86.1 NCTC 11043T Streptococcus sanguis 86.9 89.4 89.7 88.2 89.6 89.9 91.1 91.2 86.5 88.8 88.9 86.7 NCTC 7863= Streptococcus 86.7 88.9 87.0 87.8 89.3 90.0 90.6 90.9 86.5 88.6 88.4 86.2 parauberis NCDO 651 Streptococcus porcinus 86.2 88.6 86.9 87.8 89.0 89.7 90.4 90.4 87.0 87.8 88.3 86.6 NCDO 600 Streptococcus pyogenes 86.6 88.7 86.6 87.8 89.3 89.6 90.4 90.4 87.1 87.8 88.6 86.5 NCDO 2381T Te tragenococcus 89.2 90.8 91.2 90.0 92.4 93.1 93.5 93.4 88.4 89.9 90.1 88.4 halophilus NCDQ 1635= Vagococcusfluvialis 88.9 92.7 89.5 91.2 93.7 93.2 94.3 94.3 88.3 91.3 90.0 88.3 NCDO 2497T Vagococcus 88.5 91.7 90.0 90.1 94.4 93.9 94.1 94.6 87.0 90.2 90.5 86.9 salmoninarum NCFB 2777= €'96 8'16 E'68 9-88 0'68 8'68 6'68 1'16 9'06 8'06 6-88 0'98 E'68 9'88 $238 9'06 L'16 0'68 P'88 9-88 6'68 9'68 S'T6 €76 1-16 E'88 O'L8 9'68 8'L8 1'68 0'16 0'68 2'06 2-16 S'06 5-68 8'68 0'16 E'06 S'68 9'L8 2-88 2-18 S-88 0.68 9'96 1'16 0'96 0'98 L'88 L'88 6'L8 9-18 S-98 L-26 S-16 6-88 8'L8 L'16 S'S6 6'S8 7-88 S'L8 S'L8 8'LS 9-98 S.26 8-16 0'88 S'L8 L'96 L's8 P'88 0'88 P'l8 P'88 8'98 S'Z6 9-16 2-88 9'L8 6'98 E'68 9'68 P'88 2'68 8'18 0'26 8'06 9'68 P'88 1'88 E'88 9'06 6'98 6'P8 0'58 8'98 6'S8 1'L8 9'96 0-68 9'68 I'L8 9'68 0'88 L'E6 9'96 1'68 2'06 9'98 0'68 6'88 2-96 E'96 1'88 1-98 8'18 6'98 6'L8 9'88 0'16 €38 O'L8 8'06 9'06 L'S8 9'S8 S'88 2'28 O'S6 6'L8 S'88 0'88 S'L8 1-26 82 AGUIRRE AND COLLINS INT.
Load more

Recommended publications
  • Genomic Stability and Genetic Defense Systems in Dolosigranulum Pigrum A
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.16.440249; this version posted April 18, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Genomic Stability and Genetic Defense Systems in Dolosigranulum pigrum a 2 Candidate Beneficial Bacterium from the Human Microbiome 3 4 Stephany Flores Ramosa, Silvio D. Bruggera,b,c, Isabel Fernandez Escapaa,c,d, Chelsey A. 5 Skeetea, Sean L. Cottona, Sara M. Eslamia, Wei Gaoa,c, Lindsey Bomara,c, Tommy H. 6 Trand, Dakota S. Jonese, Samuel Minote, Richard J. Robertsf, Christopher D. 7 Johnstona,c,e#, Katherine P. Lemona,d,g,h# 8 9 aThe Forsyth Institute (Microbiology), Cambridge, MA, USA 10 bDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital 11 Zurich, University of Zurich, Zurich, Switzerland 12 cDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental 13 Medicine, Boston, MA, USA 14 dAlkek Center for Metagenomics & Microbiome Research, Department of Molecular 15 Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA 16 eVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, 17 Seattle, WA, USA 18 fNew England Biolabs, Ipswich, MA, USA 19 gDivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, 20 Boston, MA, USA 21 hSection of Infectious Diseases, Texas Children’s Hospital, Department of Pediatrics, 22 Baylor College of Medicine, Houston, Texas, USA 23 bioRxiv preprint doi: https://doi.org/10.1101/2021.04.16.440249; this version posted April 18, 2021.
    [Show full text]
  • The Microbiome of Otitis Media with Effusion and the Influence of Alloiococcus Otitidis on Haemophilus Influenzae in Polymicrobial Biofilm
    The microbiome of otitis media with effusion and the influence of Alloiococcus otitidis on Haemophilus influenzae in polymicrobial biofilm Chun L Chan Bachelor of Radiography and Medical Imaging (Honours) Bachelor of Medicine, Bachelor of Surgery Department of Otolaryngology, Head and Neck Surgery University of Adelaide, Adelaide, Australia Submitted for the title of Doctor of Philosophy November 2016 C L Chan i This thesis is dedicated to those who have sacrificed the most during my scientific endeavours My amazing family Flora, Aidan and Benjamin C L Chan ii Table of Contents TABLE OF CONTENTS .............................................................................................................................. III THESIS DECLARATION ............................................................................................................................. VII ACKNOWLEDGEMENTS ........................................................................................................................... VIII THESIS SUMMARY ................................................................................................................................... X PUBLICATIONS ARISING FROM THIS THESIS .................................................................................................. XII PRESENTATIONS ARISING FROM THIS THESIS ............................................................................................... XIII ABBREVIATIONS ...................................................................................................................................
    [Show full text]
  • Type of the Paper (Article
    Supplementary Materials S1 Clinical details recorded, Sampling, DNA Extraction of Microbial DNA, 16S rRNA gene sequencing, Bioinformatic pipeline, Quantitative Polymerase Chain Reaction Clinical details recorded In addition to the microbial specimen, the following clinical features were also recorded for each patient: age, gender, infection type (primary or secondary, meaning initial or revision treatment), pain, tenderness to percussion, sinus tract and size of the periapical radiolucency, to determine the correlation between these features and microbial findings (Table 1). Prevalence of all clinical signs and symptoms (except periapical lesion size) were recorded on a binary scale [0 = absent, 1 = present], while the size of the radiolucency was measured in millimetres by two endodontic specialists on two- dimensional periapical radiographs (Planmeca Romexis, Coventry, UK). Sampling After anaesthesia, the tooth to be treated was isolated with a rubber dam (UnoDent, Essex, UK), and field decontamination was carried out before and after access opening, according to an established protocol, and shown to eliminate contaminating DNA (Data not shown). An access cavity was cut with a sterile bur under sterile saline irrigation (0.9% NaCl, Mölnlycke Health Care, Göteborg, Sweden), with contamination control samples taken. Root canal patency was assessed with a sterile K-file (Dentsply-Sirona, Ballaigues, Switzerland). For non-culture-based analysis, clinical samples were collected by inserting two paper points size 15 (Dentsply Sirona, USA) into the root canal. Each paper point was retained in the canal for 1 min with careful agitation, then was transferred to −80ºC storage immediately before further analysis. Cases of secondary endodontic treatment were sampled using the same protocol, with the exception that specimens were collected after removal of the coronal gutta-percha with Gates Glidden drills (Dentsply-Sirona, Switzerland).
    [Show full text]
  • Reviewing the Pathogenic Potential of the Otitis-Associated Bacteria Alloiococcus Otitidis and Turicella Otitidis
    REVIEW published: 14 February 2020 doi: 10.3389/fcimb.2020.00051 Reviewing the Pathogenic Potential of the Otitis-Associated Bacteria Alloiococcus otitidis and Turicella otitidis Rachael Lappan 1,2, Sarra E. Jamieson 3 and Christopher S. Peacock 1,3* 1 The Marshall Centre for Infectious Diseases Research and Training, School of Biomedical Sciences, The University of Western Australia, Perth, WA, Australia, 2 Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, The University of Western Australia, Perth, WA, Australia, 3 Telethon Kids Institute, The University of Western Australia, Perth, WA, Australia Alloiococcus otitidis and Turicella otitidis are common bacteria of the human ear. They have frequently been isolated from the middle ear of children with otitis media (OM), though their potential role in this disease remains unclear and confounded due to their presence as commensal inhabitants of the external auditory canal. In this review, we summarize the current literature on these organisms with an emphasis on their role in Edited by: OM. Much of the literature focuses on the presence and abundance of these organisms, Regie Santos-Cortez, and little work has been done to explore their activity in the middle ear. We find there University of Colorado, United States is currently insufficient evidence available to determine whether these organisms are Reviewed by: Kevin Mason, pathogens, commensals or contribute indirectly to the pathogenesis of OM. However, The Ohio State University, building on the knowledge currently available, we suggest future approaches aimed at United States providing stronger evidence to determine whether A. otitidis and T. otitidis are involved in Joshua Chang Mell, Drexel University, United States the pathogenesis of OM.
    [Show full text]
  • Microbiota Network and Mathematic Microbe Mutualism in Colostrum and Mature Milk Collected in Two Different Geographic Areas: Italy Versus Burundi
    The ISME Journal (2017) 11, 875–884 OPEN © 2017 International Society for Microbial Ecology All rights reserved 1751-7362/17 www.nature.com/ismej ORIGINAL ARTICLE Microbiota network and mathematic microbe mutualism in colostrum and mature milk collected in two different geographic areas: Italy versus Burundi Lorenzo Drago1,2, Marco Toscano1, Roberta De Grandi2, Enzo Grossi3, Ezio M Padovani4 and Diego G Peroni5,6 1Clinical Chemistry and Microbiology Laboratory, IRCCS Galeazzi Orthopaedic Institute, Milan, Italy; 2Clinical Microbiology Laboratory, Department of Biomedical Science for Health, University of Milan, Milan, Italy; 3Villa Santa Maria Institute, Via IV Novembre Tavernerio, Como, Italy; 4Pediatric Department, University of Verona & Pro-Africa Foundation, Verona, Italy; 5Department of Clinical and Experimental Medicine, Section of Pediatrics, University of Pisa, Pisa, Italy and 6International Inflammation (in-FLAME) Network of the World Universities Network, Sydney, NSW, Australia Human milk is essential for the initial development of newborns, as it provides all nutrients and vitamins, such as vitamin D, and represents a great source of commensal bacteria. Here we explore the microbiota network of colostrum and mature milk of Italian and Burundian mothers using the auto contractive map (AutoCM), a new methodology based on artificial neural network (ANN) architecture. We were able to demonstrate the microbiota of human milk to be a dynamic, and complex, ecosystem with different bacterial networks among different populations containing diverse microbial hubs and central nodes, which change during the transition from colostrum to mature milk. Furthermore, a greater abundance of anaerobic intestinal bacteria in mature milk compared with colostrum samples has been observed. The association of complex mathematic systems such as ANN and AutoCM adopted to metagenomics analysis represents an innovative approach to investigate in detail specific bacterial interactions in biological samples.
    [Show full text]
  • Lactic Acid Bacteria and Their Bacteriocins: Classification, Biosynthesis and Applications Against Uropathogens: a Mini-Review
    molecules Review Lactic Acid Bacteria and Their Bacteriocins: Classification, Biosynthesis and Applications against Uropathogens: A Mini-Review Mduduzi Paul Mokoena Discipline of Microbiology, School of Life Sciences, College of Agriculture, Engineering and Science, University of KwaZulu-Natal, Westville Campus, Private Bag X54001, Durban 4000, South Africa; [email protected]; Tel.: + 27-31-260-7405 Received: 6 June 2017; Accepted: 25 July 2017; Published: 26 July 2017 Abstract: Several lactic acid bacteria (LAB) isolates from the Lactobacillus genera have been applied in food preservation, partly due to their antimicrobial properties. Their application in the control of human pathogens holds promise provided appropriate strains are scientifically chosen and a suitable mode of delivery is utilized. Urinary tract infection (UTI) is a global problem, affecting mainly diabetic patients and women. Many uropathogens are developing resistance to commonly used antibiotics. There is a need for more research on the ability of LAB to inhibit uropathogens, with a view to apply them in clinical settings, while adhering to strict selection guidelines in the choice of candidate LAB. While several studies have indicated the ability of LAB to elicit inhibitory activities against uropathogens in vitro, more in vivo and clinical trials are essential to validate the efficacy of LAB in the treatment and prevention of UTI. The emerging applications of LAB such as in adjuvant therapy, oral vaccine development, and as purveyors of bioprotective agents, are relevant in infection prevention and amelioration. Therefore, this review explores the potential of LAB isolates and their bacteriocins to control uropathogens, with a view to limit clinical use of antibiotics.
    [Show full text]
  • Skin-Gut-Breast Microbiota Axes • Lorenzo Drago Skin-Gut-Breast Microbiota Axes
    Skin-Gut-Breast Axes Microbiota • Lorenzo Drago Skin-Gut-Breast Microbiota Axes Edited by Lorenzo Drago Printed Edition of the Special Issue Published in Journal of Clinical Medicine www.mdpi.com/journal/jcm Skin-Gut-Breast Microbiota Axes Skin-Gut-Breast Microbiota Axes Editor Lorenzo Drago MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade • Manchester • Tokyo • Cluj • Tianjin Editor Lorenzo Drago Department of Biochemical Sciences for Health, University of Milan Italy Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Journal of Clinical Medicine (ISSN 2077-0383) (available at: https://www.mdpi.com/journal/jcm/ special issues/SGB MA). For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Volume Number, Page Range. ISBN 978-3-0365-0898-6 (Hbk) ISBN 978-3-0365-0899-3 (PDF) © 2021 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Editor .............................................. vii Preface to ”Skin-Gut-Breast Microbiota Axes” ............................. ix Ivan Kushkevych, Olgaˇ Leˇsˇcanov´a, Dani Dordevi´c, Simona Janˇc´ıkov´a, Jan Hoˇsek, Monika V´ıtˇezov´a, Leona Bunkov´ ˇ a and Lorenzo Drago The Sulfate-Reducing Microbial Communities and Meta-Analysis of Their Occurrence during Diseases of Small–Large Intestine Axis Reprinted from: J.
    [Show full text]
  • Alloiococcus Otitis Gen
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Jan. 1992, p. 79-83 Vol. 42, No, 1 0020-7713/92/010079-05$02.OO/O Copyright 0 1992, International Union of Microbiological Societies Phylogenetic Analysis of Alloiococcus otitis gen. nov. sp. nov. an Organism from Human Middle Ear Fluid M. AGUIRRE AND M. D. COLLINS* Department of Microbiology, AFRC Institute of Food Research, Reading Laboratory, Shinjield, Reading RG2 9AT, United Kingdom The partial 16s rRNA sequence of an unknown bacterium that was originally isolated from middle ear fluids of children with persistent otitis media was determined by reverse transcription. A comparison of this sequence with sequences from other gram-positive species having low guanine-plus-cytosine contents revealed that this bacterium represents a new line of descent, for which the name Alloiococcus otitis gen. nov., sp. nov,, is proposed. The type strain is strain NCFB 2890. Faden and Dryja (7) recently reported the isolation of an MATERIALS AND METHODS unknown organism from typanocentesis fluid collected from middle ears of young children who were suffering from Cultures and biochemical tests. Strains 3621, 4491, 7213, chronic otitis media. The cells of this bacterium were large and 7760T (T = type strain) were received from D. H. Batts gram-positive cocci (often present as diplococci or tetrads) and R. R. Hinshaw, Upjohn Laboratories, Kalamazoo, which phenotypically most closely resembled aerococci and Mich. Cultures were grown on blood agar plates and Todd- streptococci (7). However, the organism differed from aero- Hewitt broth (Oxoid Ltd., Basingstoke, United Kingdom) cocci and streptococci in being catalase positive. Despite supplemented with 5% horse serum at 37°C.
    [Show full text]
  • Establishment of the Nasal Microbiota in the First 18 Months of Life – Correlation with Early Onset Rhinitis and Wheezing
    Europe PMC Funders Group Author Manuscript J Allergy Clin Immunol. Author manuscript; available in PMC 2019 January 01. Published in final edited form as: J Allergy Clin Immunol. 2018 July ; 142(1): 86–95. doi:10.1016/j.jaci.2018.01.032. Europe PMC Funders Author Manuscripts Establishment of the Nasal Microbiota in the first 18 Months of Life – Correlation with Early Onset Rhinitis and Wheezing Le Duc Huy Ta, BSc1, Gaik Chin Yap, MSc1, Carina Jing Xuan Tay1, Alicia Shi Min Lim1, Chiung Hui Huang, PhD1, Collins Wenhan Chu, BSc2, Paola Florez De Sessions, PhD2, Lynette P Shek, MMed1, Anne Goh, MMed3, Hugo P. S. Van Bever, PhD1, Oon Hoe Teoh, MMed3, Jian Yi Soh, MMed1, Biju Thomas, MMed3, Mahesh Babu Ramamurthy, MMed1, Daniel Y. T. Goh, MMed1, Christophe Lay, PhD1,4, Shu-E Soh, PhD1, Yiong Huak Chan, PhD6, Seang-Mei Saw, PhD5, Kenneth Kwek, MMed7, Yap-Seng Chong, PhD8,9, Keith M. Godfrey, PhD10, Martin Lloyd Hibberd, PhD2, and Bee Wah Lee, MD1 1Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore 2Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore 3Department of Paediatrics Allergy and Respiratory, KK Children's and Women's Hospital, Singapore, Singapore 4Danone Nutricia Research, Singapore 5Saw Swee Hock School of Public Health, National University of Singapore, Singapore 6Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Europe PMC Funders Author Manuscripts Singapore 7Department of Maternal and Fetal Medicine, KK
    [Show full text]
  • Characterization of Bacterial Communities in Selected Smokeless Tobacco Products Using 16S Rdna Analysis Robert E
    Characterization of bacterial communities in selected smokeless tobacco products using 16S rDNA analysis Robert E. Tyx, Centers for Disease Control and Prevention Stephen B. Stanfill, Centers for Disease Control and Prevention Lisa M. Keong, Centers for Disease Control and Prevention Angel J. Rivera, Centers for Disease Control and Prevention Glen Alan Satten, Emory University Clifford H. Watson, Centers for Disease Control and Prevention Journal Title: PLoS ONE Volume: Volume 11, Number 1 Publisher: Public Library of Science | 2016-01-01, Pages e0146939-e0146939 Type of Work: Article | Final Publisher PDF Publisher DOI: 10.1371/journal.pone.0146939 Permanent URL: https://pid.emory.edu/ark:/25593/tg15k Final published version: http://dx.doi.org/10.1371/journal.pone.0146939 Copyright information: This is an Open Access work distributed under the terms of the Creative Commons Universal : Public Domain Dedication License (http://creativecommons.org/publicdomain/zero/1.0/). Accessed September 27, 2021 4:22 PM EDT RESEARCH ARTICLE Characterization of Bacterial Communities in Selected Smokeless Tobacco Products Using 16S rDNA Analysis Robert E. Tyx1*, Stephen B. Stanfill1, Lisa M. Keong1,4, Angel J. Rivera1,3, Glen A. Satten2, Clifford H. Watson1 1 Division of Laboratory Sciences at the Centers for Disease Control and Prevention, Atlanta, GA, United States of America, 2 Division of Reproductive Health, Center for Disease Control and Prevention, Atlanta, GA, United States of America, 3 Oak Ridge Institute of Science and Education, Oak Ridge, TN, United States of America, 4 Battelle Analytical Services, Atlanta, GA, United States of America a11111 * [email protected] Abstract The bacterial communities present in smokeless tobacco (ST) products have not previously OPEN ACCESS reported.
    [Show full text]
  • Lactic Acid Bacteria and Fermentation of Cereals and Pseudocereals 225
    ProvisionalChapter chapter 12 Lactic Acid Bacteria and Fermentation ofof CerealsCereals andand Pseudocereals Pseudocereals Denisa Liptáková, Zuzana Matejčeková and ĽubomírDenisa Liptáková, Valík Zuzana Matejčeková and Ľubomír Valík Additional information is available at the end of the chapter Additional information is available at the end of the chapter http://dx.doi.org/10.5772/65459 Abstract The usage of lactic acid bacteria (LAB) in food as starters in fermentation technologies has a long tradition. Although the theorized idea of host‐friendly bacteria found in yoghurt has been formulated only over a century ago, both groups are widely used nowadays. Lactic acid bacteria alone or with special adjunct probiotic strains are inevitable for the preparation of various specific fermented and probiotic foods. Moreover, because of their growth and metabolism, the final products are preserved for a certain time. Growth dynamics of probiotic LAB and Fresco DVS 1010 in milk‐ and water‐based maize mashes with sucrose or flavours (chocolate, caramel and vanilla) were evaluated in this study. Although milk is typical growth medium for the LAB growth, observed strains showed sufficient growth in each of prepared mashes as well as they were able to maintain their content above 106 CFU ml‐1 during storage period (6°C/21 d). Designed flavoured mashes were acceptable from the microbiological point of view, but according to the sensory evaluation they were provided with an attractive overall acceptability and are adequate alternative for celiac patients, people suffering from milk protein allergies or lactose intolerance. Keywords: lactic acid bacteria, fermentation, biopreservation, probiotics, functional products 1. Introduction For centuries, human civilization had used different approaches to preserve different types of food products.
    [Show full text]
  • Supplemental Data File 1: OTU Table (Includes Non-16S Sequences)
    25 535 Supplemental Data file 1: OTU Table (includes non-16S sequences) 536 # Constructed from biom file #OTU ID skoal taxonomy Otu1191 24 d:Bacteria(0.9951) p:Firmicutes(0.1465) c:Bacilli(0.0900) o:Lactobacillales(0.0344) f:Carnobacteriaceae(0.0125) g:Alloiococcus(0.0019) Otu814 121 d:Bacteria(0.9951) p:Firmicutes(0.3837) c:Bacilli(0.2164) o:Lactobacillales(0.0310) f:Lactobacillaceae(0.0114) g:Lactobacillus(0.0019) Otu492 171 d:Bacteria(0.9951) p:Firmicutes(0.5458) c:Bacilli(0.3071) o:Lactobacillales(0.0710) f:Enterococcaceae(0.0302) g:Tetragenococcus(0.0032) Otu973 616 d:Bacteria(1.0000) p:Firmicutes(0.6134) c:Bacilli(0.3893) o:Lactobacillales(0.2035) f:Carnobacteriaceae(0.0938) g:Atopostipes(0.0236) Otu1309 369 d:Bacteria(1.0000) p:Firmicutes(0.6134) c:Bacilli(0.3893) o:Lactobacillales(0.1239) f:Leuconostocaceae(0.0536) g:Weissella(0.0102) Otu1326 64 d:Bacteria(1.0000) p:Firmicutes(0.6134) c:Bacilli(0.3071) o:Lactobacillales(0.1239) f:Carnobacteriaceae(0.0419) g:Dolosigranulum(0.0023) Otu1016 1312 d:Bacteria(1.0000) p:Firmicutes(0.7485) c:Bacilli(0.5525) o:Lactobacillales(0.3117) f:Carnobacteriaceae(0.1610) g:Atopostipes(0.0236) Otu173 3030 d:Bacteria(1.0000) p:Firmicutes(0.8161) c:Bacilli(0.6341) o:Lactobacillales(0.2846) f:Aerococcaceae(0.0652) g:Ignavigranum(0.0146) Otu448 12472 d:Bacteria(1.0000) p:Firmicutes(0.8837) c:Bacilli(0.7157) o:Lactobacillales(0.4198) f:Carnobacteriaceae(0.1610) g:Marinilactibacillus(0.0236) Otu70 4316 d:Bacteria(1.0000) p:Firmicutes(0.9174) c:Bacilli(0.7565) o:Lactobacillales(0.2846) f:Lactobacillaceae(0.1442)
    [Show full text]